Variant report
Variant | esv16597 |
---|---|
Chromosome Location | chr8:63806089-63809086 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4329266 | chr8:63806099-63806100 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs551361559 | chr8:63806106-63806107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557177123 | chr8:63806121-63806122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs144989944 | chr8:63806132-63806133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546213287 | chr8:63806167-63806168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs148052268 | chr8:63806172-63806173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572722551 | chr8:63806180-63806181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs71559382 | chr8:63806203-63806204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35807349 | chr8:63806211-63806212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200921352 | chr8:63806221-63806222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs62512466 | chr8:63806222-63806223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9298067 | chr8:63806223-63806224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77606748 | chr8:63806225-63806226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201797037 | chr8:63806229-63806230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561727213 | chr8:63806246-63806247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529039366 | chr8:63806247-63806248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs16929792 | chr8:63806250-63806251 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs185866361 | chr8:63806352-63806353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533241959 | chr8:63806357-63806358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557059894 | chr8:63806378-63806379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573400498 | chr8:63806382-63806383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141793704 | chr8:63806466-63806467 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566783585 | chr8:63806467-63806468 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555555571 | chr8:63806497-63806498 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4368971 | chr8:63806538-63806539 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs546627271 | chr8:63806549-63806550 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76151090 | chr8:63806586-63806587 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs35600170 | chr8:63806590-63806591 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs36084686 | chr8:63806616-63806617 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369300804 | chr8:63806651-63806652 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs138576010 | chr8:63806658-63806659 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550745122 | chr8:63806719-63806720 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541714397 | chr8:63806720-63806721 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142841302 | chr8:63806729-63806730 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4434615 | chr8:63806777-63806778 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs72655040 | chr8:63806784-63806785 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs35185265 | chr8:63806787-63806788 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs573491124 | chr8:63806812-63806813 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190020433 | chr8:63806871-63806872 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs200684677 | chr8:63806880-63806881 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573759035 | chr8:63806892-63806893 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs13439827 | chr8:63806906-63806907 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544359551 | chr8:63806913-63806914 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs201937869 | chr8:63806936-63806937 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181155169 | chr8:63806976-63806977 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139571525 | chr8:63806981-63806982 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs4478566 | chr8:63806992-63806993 | Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs560175518 | chr8:63806996-63806997 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563797739 | chr8:63806997-63806998 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs527624223 | chr8:63807004-63807005 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:63803200-63806200 | Weak transcription | GM12878-XiMat | blood |
2 | chr8:63806200-63806400 | Enhancers | GM12878-XiMat | blood |
3 | chr8:63806400-63807400 | Flanking Active TSS | GM12878-XiMat | blood |
4 | chr8:63807200-63808000 | Enhancers | Primary B cells from peripheral blood | blood |
5 | chr8:63807400-63807600 | Enhancers | GM12878-XiMat | blood |